COMMUNIQUÉS West-GlobeNewswire

Saniona publishes its interim report for the second quarter 2018
22/08/2018
PRESS RELEASE August 22, 2018 Financial highlights H1 2018 (H1 2017) Net revenues were SEK 8.1 M (11.9 M) EBIT was SEK -39.9 M (-25.4 M) Net profit/loss was SEK -33.0 M (-21.1 M) Earnings per share were SEK -1.51 (-1.00 [...]
Half-Year Report January-June 2018
22/08/2018
Summary APRIL-JUNE IN BRIEF All planned submissions of clinical trial applications to health authorities and ethical committees for PledOx ® in Europe has been submitted. The European investigator meeting for the POLAR [...]
Interim Report Q2 2018: Continued double digit organic revenue growth drives strong EBITA margin increase. GN Audio upgrades organic growth guidance
22/08/2018
GN Store Nord delivered 11% organic revenue growth in Q2 2018. Revenue growth was 7% including around (5)% impact from development in foreign exchange rates EBITA margin increased 1.5 percentage points in Q2 2018 as a [...]
Kane Biotech Announces Second Quarter 2018 Financial Results
21/08/2018
WINNIPEG, Manitoba, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its Second Quarter 2018 Financial Results. Kane Biotech Inc. is a [...]
Neon Therapeutics Appoints Jolie M. Siegel as General Counsel
21/08/2018
CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the appointment of Jolie M. [...]
Rubius Therapeutics to Announce Second Quarter 2018 Financial Results
21/08/2018
CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, plans to report second [...]
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
21/08/2018
Total Fourth-Quarter Revenues of $200.9 Million Fourth-Quarter Diluted EPS of $0.18 and Adjusted EPS of $0.38, Up 31 Percent SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad [...]
Dermavant Sciences Announces Closing of Transaction With GSK for Purchase of Rights to Tapinarof
21/08/2018
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a subsidiary of Roivant Sciences, today announced the closing of its transaction with GSK, executed on July 10, 2018, for the purchase of all global rights [...]
NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare
21/08/2018
WALTHAM, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK Consumer Healthcare. A [...]
The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada
21/08/2018
DENVER, Aug. 21, 2018 (GLOBE NEWSWIRE) -- What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19 th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, [...]
NeoTherma Oncology Receives NCI Grant to Advance VectRx™ MRI Thermometry
21/08/2018
WICHITA, Kan., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the Company was recently [...]
InCrowd Named as Finalist for Vendor of the Year from PM360
21/08/2018
2018 Trailblazer Award Honors Vendors’ Commitment to The Life Sciences Through Innovation, Talent Development, Social Responsibility WATERTOWN, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- InCrowd , pioneer of the real-time [...]
Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy of LB-100 in Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome
21/08/2018
EAST SETAUKET, NY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that it has entered into a Clinical Trial Agreement and Exclusive License Agreement with Moffitt Cancer [...]
Alpha II to Provide Claim Scrubbing and Medical Necessity Services to UAE-Based Manteq
21/08/2018
Relationship Furthers Alpha II’s Efforts to Validate Claims and Improve Clinical Accuracy for Healthcare Providers Internationally TALLAHASSEE, Fla., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer [...]
Innovation in school mental health literacy underway across Canada
21/08/2018
HALIFAX, Nova Scotia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- The team behind TeenMentalHealth.Org is working to improve mental health literacy in schools nationally through the launch of a new course, Teach Mental Health. [...]
NewLink Genetics to Participate in the Baird Global Healthcare Conference
21/08/2018
AMES, Iowa, Aug. 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company will present at the 2018 Baird Global Healthcare Conference on Wednesday, September 5, 2018, at [...]
Lexington Announces First Multicenter Clinical Study Site
21/08/2018
Company embarks on pivotal clinical study VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical [...]
Company update: Global Kinetics Corporation hits significant clinical milestones on its trajectory to revolutionise the treatment of Parkinson’s disease
21/08/2018
Leading digital health company Global Kinetics’ ground-breaking PKG™ technology recommended by world leading Parkinson’s experts ahead of achieving a key milestone on the path to USA reimbursement PORTSMOUTH, N.H. and [...]
Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
21/08/2018
Mandesh Dosanjh brings extensive consumer products experience with recent cannabis focus at Liquor Control Board of Ontario VICTORIA, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc [...]

Pages